what dose of tirzepatide for maintenance After Weight Loss Staying on a Tirzepatide Maintenance

BP-157 (15-amino acid pentadecapeptide) is a synthetic derivative of human gastric juice, and its promoted online as having incredible healing capabilities and also for performance and longevity, none of which have ever been substantiated in anything other than rodents

The challenge is maintaining results after treatment ends, which requires the lifestyle, nutrition, and exercise habits you build during treatment

Your provider will guide this decision based on your response

At week 36, the following differences were observed for change in 24-hour diastolic blood pressure from baseline relative to placebo therapy: Tirzepatide 5 mg: -2.0 (95% CI, -3.6 to -0.3) mmHg Tirzepatide 10 mg: -2.9 (95% CI, -4.5 to -1.3) mmHg Tirzepatide 15 mg: -0.5 (95% CI, -2.0 to 1.1) mmHg Further analysis suggested these results were consistent across subgroups defined by clinically relevant factors, including age, sex, BMI, and hypertension-related factors

Tirzepatide is a dual agonist that activates both GIP and GLP-1 receptors, while existing medications only target GLP-1 receptors